This interview is part of the opening ceremony of the Expert Diploma in Exposome & Skin: Diet, Microbiota, Quality of life, and Mental Health. Thisconversation highlights the evolution and crucial role that microbiota research has played in health, especially in skin diseases and immune response, and highlights its potential to improve treatments for diseases such as cancer.

Dr. Susana Puig, a world leader in the diagnosis and treatment of melanoma and skin cancer, leads the Higher University Course on Environment, photodamage and photoaging.

The creation of the original contents of the course corresponds to the professors of the International School of Derma: a group of prestigious international experts in medicine and dermatology. Each of them is the author of the topics that she will teach throughout the course.

Doctor of Philosophy. He did his PhD at the University of Oxford (UK) studying the pathophysiology of severe malaria. He became an independent researcher in 2008 (MRC Clinician Scientist Fellowship) and his main research interests are biomarker discovery, microbiome analysis, and artificial intelligence applied to infectious diseases.

Diet, Microbiota, Quality of Life, and Mental Health

test-en

How to Use Microbiota in the Treatment of Skin Diseases. The Human Microbiome Project

The human microbiome project revealed that the microorganisms in our body contain more genes than the body's own. Discover how the food we eat, its relationship to circadian rhythm and the brain-gut connection modulate our body's immune function through the microbiome.

The Human Microbiome Project

This talk explores myths, truths, and challenges related to Artificial Intelligence (AI). AI is not just a trend but a technology poised to enhance human potential and improve life quality. It will transform jobs rather than eliminate them and demands that we address ethical and privacy concerns through global consensus. AI’s development presents risks if not managed carefully, emphasizing the need for transparency and education. We must enhance our ethical frameworks and return to the art of asking insightful questions, as the quality of our questions will shape AI’s impact.

Optimist lifelong learning innovator adopted by Barcelona. Global Director of Digital Skin at ISDIN (CDSO), Former CEO at Advances in Surgery (now Founding Partner & Advisor), Partner at Modyo, Masterclass Faculty at University of Barcelona, UCL and Stanford U., PUZZLE X board member, UNESCO committee member on ethical use of Artificial Intelligence & mountainbike/snowboard enthusiastic.

Myths and truths of artificial intelligence

Advances in recent years in the genetic study of the intestinal microbiome allow us to recognize it as an immune organ with a high microbiological diversity.
recognize it as an immune organ of high microbiological diversity. Modern dietary patterns in Western countries, the use of processed foods, the abuse of antibiotics, among others, alter the composition of the microbiome. This video highlights their intimate relationship with diet and the impact they have on our health.

Dr. Bataille graduated from the Leuven Faculty of Medicine in Brussels. She began her training in dermatology at the St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust London. Then worked at the Imperial Cancer Research Fund in London and at the Royal London Hospital as a Clinical Research Fellow where she completed his PhD in the genetic epidemiology of melanoma in 1995. She has worked with the National Health Service (NHS) in England for over 35 years since 1985. In her teaching career, she was a Senior Lecturer in Dermatology at Barts and London and Queen Mary College from 1996 to 2003 and then was affiliated with the University of Hertfordshire from 2004 where she created the MsC in dermatology for nurses and allied health professionals. She is also an academic dermatologist at King’s College, St Thomas Hospital Campus since 1996 in charge of the dermatology research at the Twin Research UK department (www.twinsuk.ac.uk) In 2004, joined the West Herts NHS Trust, where she was the skin cancer lead for the MDT and network. Currently, she continues to work at the Combined Oncology Clinics in Mount Vernon caring for patients with stage 3 and 4 melanoma. Also runs a monthly tertiary clinic for familial melanoma and familial cancer syndromes and continues her academic work at King's College. Her research has focused on melanoma, naevi and skin pigmentation for the past 25 years. She has supervised various MD and Ph students at Queen Mary College and King's College, London and published in many national and international journals. Her research is currently focused on the role of the gut microbiome in responses to immunotherapy in advanced melanoma with a large European consortium (www.seerave.org). She is also involved in COVID research looking at the cutaneous manifestations of COVID infection and the vaccine.

Dermatological news for July

Watch next